A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS

Health Technol Assess. 2002;6(26):1-112. doi: 10.3310/hta6260.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review
  • Systematic Review

MeSH terms

  • Brain Ischemia / drug therapy
  • Brain Ischemia / economics
  • Cost-Benefit Analysis*
  • Diffusion of Innovation
  • Humans
  • Neuroprotective Agents / economics
  • Neuroprotective Agents / therapeutic use*
  • State Medicine / organization & administration*
  • Stroke / drug therapy*
  • Stroke / economics
  • Thrombolytic Therapy / economics*
  • Treatment Outcome*
  • United Kingdom

Substances

  • Neuroprotective Agents